21st Austria weekly - Croma-Pharma AT&S SBO 01/06/2023 [pic1]Croma-Pharma: an Austrian based global player and challenger in the minimally invasive aesthetics market announces that it will launch Pliaglis® a topical local anaesthetic for superficial dermatological procedures its European core markets including Germany United Kingdom "UK" Ireland. Further Brazil follow by end of 2023. The cream complements Croma s range aesthetic injectables key pillar comprehensive innovative portfolio. is preceded exclusive licensing agreement Pliaglis® with Canadian